HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inken Floerkemeier Selected Research

NSC 366140 (pyrazoloacridine)

1/2022The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Inken Floerkemeier Research Topics

Disease

1Leukemia
01/2022

Drug/Important Bio-Agent (IBA)

1NSC 366140 (pyrazoloacridine)IBA
01/2022
1Irinotecan (Camptosar)FDA LinkGeneric
01/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1Topoisomerase InhibitorsIBA
01/2022